Edition:
United Kingdom

Greenhill & Co Inc (GHL.N)

GHL.N on New York Stock Exchange

18.70USD
17 Jan 2018
Change (% chg)

$0.15 (+0.81%)
Prev Close
$18.55
Open
$18.50
Day's High
$18.88
Day's Low
$18.30
Volume
66,385
Avg. Vol
165,154
52-wk High
$32.30
52-wk Low
$13.80

Chart for

About

Greenhill & Co., Inc. is an investment bank. The Company provides financial and strategic advice on domestic and cross-border mergers and acquisitions, divestitures, restructurings, financings, capital raising and other transactions to a diverse client base, including corporations, partnerships, institutions and governments... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $497.93
Shares Outstanding(Mil.): 29.64
Dividend: 0.45
Yield (%): 10.71

Financials

  Industry Sector
P/E (TTM): -- 110.64 16.44
EPS (TTM): -- -- --
ROI: -- 2.51 10.61
ROE: -- 7.69 14.21

BRIEF-Scott Bok Reports 5 Percent Stake In Greenhill & Co

* SCOTT BOK REPORTS 5 PERCENT STAKE IN GREENHILL & CO INC AS ON JANUARY 10 - SEC FILING Source text: (http://bit.ly/2CYcCTS) Further company coverage:

10 Jan 2018

BRIEF-HSBC Has Appointed Anthony Parsons As Vice-Chairman, Global Banking From Greenhill

* HAS APPOINTED ANTHONY PARSONS AS VICE-CHAIRMAN, GLOBAL BANKING FROM GREENHILL Source text for Eikon: Further company coverage:

18 Dec 2017

BRIEF-Greenhill & Co reports third quarter loss per share of $0.18

* Greenhill & Co Inc reports third quarter loss per share of $0.18

18 Oct 2017

BRIEF-Greenhill & Co enters credit agreement

* Greenhill & Co Inc - ‍on October 12, co entered credit agreement - sec filing​

13 Oct 2017

BRIEF-GREENHILL ANNOUNCES INCREASE IN PLANNED SHARE REPURCHASE TO $285 MLN

* GREENHILL ANNOUNCES REVISED TERMS FOR RECAPITALIZATION AND SHARE REPURCHASE

09 Oct 2017

BRIEF-Greenhill announces plan for recapitalization and major share repurchase

* Greenhill announces plan for recapitalization and major share repurchase

25 Sep 2017

BRIEF-Mabvax Therapeutics engages Greenhill & co. as advisor for exploring strategic alternatives

* Mabvax Therapeutics engages Greenhill & Co. as advisor for exploring strategic alternatives

06 Sep 2017

BRIEF-Greenhill & Co Q2 earnings per share $0.20

* Greenhill & Co. Reports second quarter earnings per share of $0.20

27 Jul 2017

Earnings vs. Estimates